Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination

Journal of Molecular Medicine

Volumn 81, Issue 2, 2003, Pages 91-101

  Kwissa, Marcin ^a   Kröger, Andrea ^b   Hauser, Hansjörg ^b   Reimann, Jörg ^a   Schirmbeck, Reinhold ^a  

^a UNIVERSITY OF ULM   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Cytokines; Cytotoxic T lymphocyte priming; DNA vaccination; Hepatitis B surface antigen vaccine

Indexed keywords

BETA INTERFERON; CD8 ANTIGEN; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 15; PLASMID DNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; FEMALE; MOUSE; NONHUMAN; T LYMPHOCYTE; VACCINATION;

EID: 0037294176     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-002-0395-6     Document Type: Article

References (48)

1. Conry RM, Widera G, LoBuglio AF, Fuller JT, Moore SE, Barlow DL, Turner J, Yang N-S, Curiel DT (1996) Selected strategies to augment polynucleotide vaccination. Gene Ther 3:67-74
2. Pasquini S, Xiang Z, Wang Y, He Z, Deng H, Blaszczyk TM, Ertl HC (1997) Cytokines and costimulatory molecules as genetic adjuvants. Immunol Cell Biol 75:397-401
3. Kim JJ, Nottingham LK, Wilson DM, Bagarazzi ML, Tsai A, Morrison LD, Javadian A, Chalian AA, Agadjanyan MG, Weiner DB (1998) Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine 16:1828-1835
4. Kipps T, Mendoza R (1999) Extending genetic vaccines with chemokines. Nat Biotechnol 17:226-227
5. Scheerlinck JY (2001) Genetic adjuvants for DNA vaccines. Vaccine 19:2647-2656
6. Nicolet CM, Burkholder JK, Gan J, Culp J, Kashmiri SV, Schlom J, Yang NS, Sondel PM (1995) Expression of a tum or-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery. Cancer Gene Ther 2:161-170
7. Sun WH, Burkholder JK, Sun J, Culp J, Turner J, Lu XG, Pugh TD, Ershler WB, Yang NS (1995) in vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA 92:2889-2893
8. Mahvi DM, Burkholder JK, Turner J, Culp J, Malter JS, Sondel PM, Yang NS (1996) Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. Hum Gene Ther 7:1535-1543
9. Rakhmilevich AL, Turner J, Ford MJ, McCabe D, Sun WH, Sondel PM, Grota K, Yang NS (1996) Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 93:6291-6296
10. Xiang ZQ, Ertl HCJ (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135
11. Corr M, Tighe H, Lee D, Dudler J, Trieu M, Brinson DC, Carson DA (1997) Costimulation provided by DNA immunization enhances antitumor immunity. J Immunol 159:4999-5004
12. Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH (1997) Enhanced CTL responses mediated by plasmid DNA immunogenes encoding costimulatory molecules and cytokines. J Immunol 158:4591-4601
13. Chun S, Daheshia M, Kuklin NA, Rouse BT (1998) Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes. J Virol 72:5545-5551
14. Pardoll DM, Beckerleg AM (1995) Exposing the immunology of naked DNA vaccines. Immunity 3:165-169
15. Pisetsky DS (1996) The immunologic properties of DNA. J Immunol 156:421-423
16. Krieg AM, Yi AK, Schorr J, Davis HL (1998) The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 6:23-27
17. Davis HL, Schirmbeck R, Reimann J, Whalen R (1995) DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 6:1447-1456
18. Schirmbeck R, Böhm W, Ando K-I, Chisari FV, Reimann J (1995) Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 69:5929-5934
19. Böhm W, Kuhröber A, Paier T, Mertens T, Reimann J, Schirmbeck R (1996) DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J Immunol Methods 193:29-40
20. Böhm W, Mertens T, Schirmbeck R, Reimann J (1998) Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 16:949-954
21. Schirmbeck R, Wild J, Reimann J (1998) Similar as well as distinct MHC-I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg). Eur J Immunol 28:4149-4161
22. + T cell-dependent. J Immunol 163:1880-1887
23. Kwissa M, von Kampen V, Zurbriggen R, Gluck R, Reimann J, Schirmbeck R (2000) Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control. Vaccine 18:2337-2344
24. Reimann J, Schirmbeck R (2000) Modulating specific priming of immune effector functions by DNA-based vaccination strategies. Dev Biol 104:15-24
25. Schirmbeck R, Reimann J (2001) Modulation of Gene-Gun-Mediated Th2 Immunity to Hepatitis B Surface Antigen by Bacterial CpG Motifs or IL-12. Intervirology 44:115-123
26. b-restricted HBsAg epitopes. J Immunol 168:6253-6262
27. Schirmbeck R, Gerstner O, Reimann J (1999) Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expression. Eur J Immunol 29:1740-1749
28. Higashi Y, Sokawa Y, Watanabe Y, Kawade Y, Ohno S, Takaoka C, Taniguchi T (1983) Structure and expression of a cloned cDNA for mouse interferon-β. J Biol Chem 258:9522-9529
29. Artelt P, Morelle C, Ausmeier M, Fitzek M, Hauser H (1988) Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 68:213-219
30. Dinter H, Hauser H (1987) Superinduction of the human interferon-β promoter. EMBO J 6:599-604
31. d mice that reject syngeneic tumors. J Immunol 157:3550-3558
32. Ishikawa T, Kono DH, Fowler P, Theofilopoulos AN, Kakumu S, Chisari FV (1998) Polyclonality and multispecificity of the CTL response to a single viral epitope. J Immunol 161:5842-5850
33. Schirmbeck R, Deppert W, Kury E, Reimann J (1993) in vitro expansion distorts the detectable pattern of specific recognition of in vivo primed cytotoxic T lymphocyte populations. Cell Immunol 149:444-449
34. Pisetsky DS (1996) Immune activation by bacterial DNA: a new genetic code. Immunity 5:303-310
35. Carson DA, Raz E (1997) Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J Exp Med 186:1621-1622
36. Klinman DM, Yamshchikov G, Ishigatsubo Y (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158:3635-3639
37. Roman M, Martin OE, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3:849-854
38. Tighe H, Corr M, Roman M, Raz E (1998) Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19:89-97
39. Weeratna R, Brazolot MC, Krieg AM, Davis HL (1998) Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev 8:351-356
40. Feltquate DM, Heaney S, Webster RG, Robinson HL (1997) Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158:2278-2284
41. Prayaga SK, Ford MJ, Haynes JR (1997) Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine 15:1349-1352
42. Mendez S, Gurunathan S, Kamhawi S, Belkaid Y, Moga MA, Skeiky YA, Campos-Neto A, Reed S, Seder RA, Sacks D (2001) The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J Immunol 166:5122-5128
43. Bueler H, Mulligan RC (1996) Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol Med 2:545-555
44. Kwak LW, Young HA, Pennington RW, Weeks SD (1996) Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci USA 93:10972-10977
45. Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K (1997) Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159:3638-3647
46. Gerloni M, Lo D, Ballou WR, Zanetti M (1998) Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow-derived dendritic cells. Eur J Immunol 28:1832-1838
47. Sin JI, Kim JJ, Ugen KE, Ciccarelli RB, Higgins TJ, Weiner DB (1998) Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur J Immunol 28:3530-3540
48. Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, Klinman DM, Hoffman SL (1998) A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 161:2325-2332